UBS Starts Walgreens Boosts Alliance (WBA) at Buy

UBS initiates coverage on Walgreens Boosts Alliance (NASDAQ: WBA) with a Buy rating and a price target of $94.00.

Analyst Michael Cherny commented, "We are initiating coverage of Walgreens Boots Alliance with a Buy rating and a $94 price target. Walgreens is one of the two largest drug retailers in the US as well as the leading European drug retailer, with a focus on offering a combination of both convenience and differentiated products (including the No7 beauty products from Boots). The company is also in the midst of broadening its channel partnerships through a number of agreements with various different supply chain constituents, all targeted at driving improved productivity of the “box.” Note: UBS is acting as financial advisor to Walgreens in its pending acquisition of Rite Aid."

For an analyst ratings summary and ratings history on Walgreens Boosts Alliance click here. For more ratings news on Walgreens Boosts Alliance click here.

Shares of Walgreens Boosts Alliance closed at $80.51 yesterday.

You May Also Be Interested In

• Walgreens Boots Alliance (WBA) Declares $0.25 Quarterly Dividend; 5.7% Yield
• Amazon.com (AMZN) PT Raised to $215 at UBS
• Merck (MRK) PT Raised to $143 at Truist Securities